Annual report for Mangalam Drugs and Organics Ltd. for FY-2014
30-05-2014
Financial Results & Auditors Report for March 31, 2014 (Audited)
Mangalam Drugs & Organics Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2014.Shareholding Pattern For March 31, 2014
Mangalam Drugs & Organics Ltd has informed BSE about the Shareholding Pattern as on March 31, 2014.Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Smita Dhoot has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEDisclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mangalam Drugs & Organics Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Financial Results & Limited Review for Dec 31, 2013
Mangalam Drugs & Organics Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Rajkamal Sukhani has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Govardhan Murlidhar Dhoot, Brijmohan Murlidhar Dhoot & Shweta Govardhan Dhoot has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSEFinancial Results & Limited Review for Sept 30, 2013
Mangalam Drugs & Organics Ltd has informed BSE has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended Sept 30, 2013.Outcome of AGM
Mangalam Drugs & Organics Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on September 26, 2013.